Company / Revenue per Share
Enveric Biosciences, Inc. Revenue per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$25.40
FY2019
5-year range
$2.60 / $25.40
FY2017-FY2019
Trend
+849.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +849% YoY in FY2019, a notable deviation from the 2-year average annual change of +426%.
Based on SEC 10-K filings.
25.40 in FY2019.
Improved from $2.60 to $25.40 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, revenue per share increased 849.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $25.40 | +849.2% |
| FY2018 | $2.68 | +2.8% |
| FY2017 | $2.60 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026